Mankind Pharma rallied 3.14% to Rs 2,627.10 after the company’s board approved to raise funds aggregating to Rs 10,000 crore through non convertible debentures (NCDs) and commercial papers (CPs) on private placement basis.
Subscribe To Our Free Newsletter |